WebIn the mid-1980s, Sachiko joined Dr. Ryuji Ueno in establishing R-Tech Ueno Ltd. in Japan. Sachiko engaged herself in all development research, including basic research and applied research, a production, and an application for approval, and the successful launch of Rescula® eye drops, the first bioactive lipid ever used to treat glaucoma in Japan. WebDr. Ryuji Ueno is an internationally recognized researcher in pharmacology, physiology and the biochemistry of endogenic functional fatty acids and their related compounds. Dr. Ueno is a co-founder of the Sucampo Group, an international affiliation of pharmaceutical research, development and manufacturing companies.
Stella x Schubert = Rondo in B Minor; Fantasie in C Major; Sei mir ...
Web10 giu 2010 · Lubiprostone is one of the prostone compounds (functional fatty acid) identified by Dr. Ryuji Ueno, who is founder of R-Tech Ueno as well as Sucampo Group, and is the world's first Chloride Channel Activator approved as a drug. About Sucampo Pharmaceuticals, Inc. WebDr. Ryuji Ueno, M.D., Ph.D. and Ph.D. Founder and Executive Producer Trained and certified as a Medical Doctor at Keio University School of Medicine in Japan, Dr. Ueno … sports memorabilia atlanta
Ryuji Ueno Foto e immagini stock - Getty Images
Web25 mar 2014 · Dr. Ryuji Ueno is an internationally recognized expert in pharmacology, physiology and biochemistry of prostones – naturally occurring (endogenous) fatty acids - and their related compounds. Web2 giu 2014 · In 2011 there was much hubbub when biotech entrepreneurs Sachiko Kuno and Dr. Ryuji Ueno bought the two biggest and most expensive homes in Georgetown, Evermay (for $22 million) and Halcyon House (for $12.5 million). Were they his-and-her mansions for the rich founders of Bethesda-based Sucampo Pharmaceuticals? http://www.officeone.co.jp/schedule/230915.html sports memorabilia dfw